CCT020312 showed neuroprotection in cellular and mouse models of tauopathies, reducing tau phosphorylation in P301S tau mice and significantly improving their memory and motor function, with a reduction in motoneuron loss [129]. This evidence concerns the gene MAPT and tauopathy.